G-CSF receptor in progenitor mobilization

G-CSF 受体在祖细胞动员中的作用

• 批准号: 7077018
• 负责人: Daniel C Link
• 金额: $ 29.88万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-06-01 至 2009-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7077018
• 关键词: biological signal transduction; bone marrow transplantation; cell cycle; cell differentiation; cell migration; cell motility; cell type; colony stimulating factor; flow cytometry; gene expression; gene mutation; genetically modified animals; granulocyte; growth factor receptors; hematopoiesis; hematopoietic growth factor; hematopoietic stem cells; interleukin 12; laboratory mouse; neutrophil; receptor expression; transfection

DESCRIPTION (provided by applicant): The long-range objective of this research is to characterize the mechanisms that regulate the mobilization of hematopoietic progenitor cells (HPC) from the bone marrow to blood. Hematopoietic stem cell transplantation is a potentially curative therapy for patients with advanced hematological malignancies. Recently, mobilized peripheral blood HPC instead of bone marrow-derived HPC have been used because of reduced engraftment times and relative ease of collection. Current mobilization protocols utilizing granulocyte colony stimulating factor (G-CSF) alone are generally well tolerated but not universally effective and are often associated with co-mobilization of neoplastic cells. A better understanding of the mechanisms that regulate HPC mobilization may lead to the design of novel mobilization strategies that overcome these problems. Accumulating evidence suggests that interactions between stromal derived factor-1 (SDF-1, CXCL12) and its cognate receptor, CXCR4, may play a key role in regulating HPC and neutrophil trafficking from the bone marrow. Loss-of-function models for SDF-1 and CXCR4 have established a critical role for these genes in the migration of HPC from the fetal liver to bone marrow. More recently, gain-of-function mutations of the CXCR4 gene have been implicated in the pathogenesis of WHIM syndrome, a syndrome manifested, in part, by impaired neutrophil trafficking from the bone marrow. We recently showed that G-CSF treatment results in a significant decrease in SDF-1alpha protein in the bone marrow of wild type mice. Finally, treatment with AMD3100, a selective antagonist of CXCR4, induces rapid and robust HPC mobilization in mice and humans. Collectively, these data suggest a hypothesis in which disruption of SDF-1/CXCR4 signaling is a key step in HPC mobilization by G-CSF. The objective of this research is to test this hypothesis and define mechanisms by which mobilizing agents regulate SDF-1/CXCR4 signaling. The following specific aims are proposed. 1. We will determine whether gain-of-function mutations of the CXCR4 gene found in patients with WHIM syndrome are sufficient to induce impaired HPC and neutrophil trafficking from the bone marrow. 2. We will identify the mechanisms by which G-CSF regulates SDF-1 expression in the bone marrow. 3. We will determine whether disruption of SDF-1/CXCR4 signaling is a common final pathway by which diverse mobilizing agents mediate HPC mobilization.

描述（由申请人提供）：本研究的长期目标是表征调节造血祖细胞（HPC）从骨髓向血液动员的机制。造血干细胞移植是一种治疗晚期血液系统恶性肿瘤的潜在疗法。近年来，由于减少了移植次数和相对容易收集，已采用动员外周血造血干细胞代替骨髓源性造血干细胞。目前单独使用粒细胞集落刺激因子（G-CSF）的动员方案通常耐受性良好，但不是普遍有效，并且通常与肿瘤细胞的共同动员有关。更好地理解调控HPC动员的机制可能会导致设计新的动员策略来克服这些问题。